Eva Reinauer

Title: Eva Reinauer: Innovator in Fibrin Sealant Solutions

Introduction

Eva Reinauer is a notable inventor based in Eurasburg, Germany. She has made significant contributions to the field of medical solutions, particularly in the development of fibrin sealants. Her innovative work has led to the creation of a patented solution that enhances wound treatment.

Latest Patents

Eva Reinauer holds a patent for "Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit." This patent discloses a fibrinogen solution that contains fibrinogen at a concentration of at least 40 mg/ml, along with factor XIII, pharmaceutically acceptable additives, and water. The dynamic viscosity of this solution, when measured at 20° C., increases by at most 35% after being stored at the same temperature for 30 days. Additionally, the thrombin solution comprises thrombin, pharmaceutically acceptable additives, and water, with thrombin activity decreasing by at most 15% after storage at 25° C. for 14 days. The patent also includes a fibrin sealant kit that contains both the fibrinogen and thrombin solutions, along with methods for preparing a fibrin sealant and treating wounds.

Career Highlights

Throughout her career, Eva has worked with prominent companies in the medical field, including Baxter International Inc. and Leukocare AG. Her experience in these organizations has contributed to her expertise in developing innovative medical solutions.

Collaborations

Eva has collaborated with talented individuals such as Stella Grosso and Julia Rabas. These partnerships have played a crucial role in advancing her research and development efforts.

Conclusion

Eva Reinauer's contributions to the field of fibrin sealants demonstrate her commitment to innovation in medical solutions. Her patented work not only enhances wound treatment but also showcases her expertise and collaboration with industry professionals.